Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 9 X posts from 7 X users, with an upper bound of 17,272 followers.

RT @GrupoOrpharSEFH: Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis https://t.co/VFWyto7Jyp

Exon skipping for Duchenne muscular dystrophy: a systematic review and meta-analysis https://t.co/VFWyto7Jyp

RT @Share4Rare: New publication concludes that exon-skipping drugs are not effective in #Duchenne. According to authors, further research w…

RT @Share4Rare: New publication concludes that exon-skipping drugs are not effective in #Duchenne. According to authors, further research w…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.